United Capital Financial Advisors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.29M | Sell |
19,104
-326
| -2% | -$21.7K | 0.01% | 714 |
|
|
2026
Q1 | $1.22M | Sell |
19,430
-634
| -3% | -$44.1K | 0.01% | 686 |
|
|
2025
Q4 | $1.33M | Sell |
20,064
-15,401
| -43% | -$996K | 0.01% | 648 |
|
|
2025
Q3 | $2.39M | Buy |
35,465
+15,769
| +80% | +$1.25M | 0.02% | 429 |
|
|
2025
Q2 | $1.72M | Sell |
19,696
-2,158
| -10% | -$169K | 0.01% | 476 |
|
|
2025
Q1 | $1.49M | Buy |
21,854
+4,205
| +24% | +$343K | 0.01% | 482 |
|
|
2024
Q4 | $1.37M | Buy |
17,649
+6,401
| +57% | +$474K | 0.01% | 492 |
|
|
2024
Q3 | $754K | Buy |
11,248
+3,364
| +43% | +$276K | 0.01% | 611 |
|
|
2024
Q2 | $894K | Sell |
7,884
-2,194
| -22% | -$277K | 0.01% | 555 |
|
|
2024
Q1 | $1.4M | Sell |
10,078
-545
| -5% | -$68.5K | 0.01% | 494 |
|
|
2023
Q4 | $1.32M | Sell |
10,623
-5,102
| -32% | -$521K | 0.01% | 497 |
|
|
2023
Q3 | $1.47M | Sell |
15,725
-6,034
| -28% | -$680K | 0.01% | 459 |
|
|
2023
Q2 | $2.8M | Buy |
21,759
+543
| +3% | +$65.7K | 0.02% | 395 |
|
|
2023
Q1 | $2.46M | Sell |
21,216
-8,346
| -28% | -$934K | 0.01% | 419 |
|
|
2022
Q4 | $3.35M | Sell |
29,562
-407
| -1% | -$44.7K | 0.02% | 391 |
|
|
2022
Q3 | $2.41M | Sell |
29,969
-1,936
| -6% | -$164K | 0.01% | 442 |
|
|
2022
Q2 | $2.38M | Buy |
31,905
+597
| +2% | +$54.5K | 0.01% | 459 |
|
|
2022
Q1 | $4M | Buy |
31,308
+2,916
| +10% | +$319K | 0.02% | 403 |
|
|
2021
Q4 | $3.81M | Buy |
28,392
+424
| +2% | +$60.9K | 0.02% | 416 |
|
|
2021
Q3 | $3.82M | Sell |
27,968
-228
| -0.8% | -$28.8K | 0.02% | 412 |
|
|
2021
Q2 | $3.01M | Buy |
28,196
+1,620
| +6% | +$156K | 0.02% | 465 |
|
|
2021
Q1 | $2.39M | Sell |
26,576
-2,836
| -10% | -$266K | 0.01% | 472 |
|
|
2020
Q4 | $2.72M | Buy |
29,412
+20,568
| +233% | +$1.84M | 0.02% | 449 |
|
|
2020
Q3 | $911K | Sell |
8,844
-368
| -4% | -$38.4K | 0.01% | 689 |
|
|
2020
Q2 | $934K | Sell |
9,212
-628
| -6% | -$56.2K | 0.01% | 682 |
|
|
2020
Q1 | $662K | Buy |
9,840
+660
| +7% | +$41.1K | 0.01% | 729 |
|
|
2019
Q4 | $502K | Sell |
9,180
-852
| -8% | -$40.4K | ﹤0.01% | 985 |
|
|
2019
Q3 | $374K | Sell |
10,032
-2,612
| -21% | -$101K | ﹤0.01% | 1028 |
|
|
2019
Q2 | $474K | Buy |
12,644
+2,156
| +21% | +$67.8K | ﹤0.01% | 1068 |
|
|
2019
Q1 | $312K | Sell |
10,488
-5,224
| -33% | -$184K | ﹤0.01% | 1113 |
|
|
2018
Q4 | $471K | Buy |
15,712
+172
| +1% | +$5.46K | ﹤0.01% | 937 |
|
|
2018
Q3 | $556K | Sell |
15,540
-124,352
| -89% | -$3.86M | ﹤0.01% | 944 |
|
|
2018
Q2 | $3.32M | Buy |
139,892
+16,732
| +14% | +$355K | 0.02% | 491 |
|
|
2018
Q1 | $2.28M | Sell |
123,160
-1,228
| -1% | -$18.2K | 0.02% | 556 |
|
|
2017
Q4 | $1.78M | Buy |
124,388
+248
| +0.2% | +$3.22K | 0.01% | 624 |
|
|
2017
Q3 | $1.52M | Sell |
124,140
-2,780
| -2% | -$49.1K | 0.01% | 651 |
|
|
2017
Q2 | $2.32M | Buy |
126,920
+20,908
| +20% | +$386K | 0.02% | 533 |
|
|
2017
Q1 | $2.25M | Sell |
106,012
-2,576
| -2% | -$50.3K | 0.02% | 535 |
|
|
2016
Q4 | $1.62M | Sell |
108,588
-51,796
| -32% | -$918K | 0.02% | 613 |
|
|
2016
Q3 | $3.52M | Buy |
160,384
+75,232
| +88% | +$1.67M | 0.03% | 456 |
|
|
2016
Q2 | $1.68M | Sell |
85,152
-268
| -0.3% | -$4.56K | 0.02% | 595 |
|
|
2016
Q1 | $1.45M | Buy |
85,420
+276
| +0.3% | +$4.61K | 0.02% | 607 |
|
|
2015
Q4 | $1.74M | Sell |
85,144
-764
| -0.9% | -$15.9K | 0.02% | 571 |
|
|
2015
Q3 | $1.84M | Buy |
85,908
+2,852
| +3% | +$63.6K | 0.02% | 542 |
|
|
2015
Q2 | $1.66M | Buy |
83,056
+26,604
| +47% | +$467K | 0.02% | 609 |
|
|
2015
Q1 | $954K | Buy |
56,452
+2,676
| +5% | +$40.4K | 0.01% | 730 |
|
|
2014
Q4 | $740K | Buy |
53,776
+728
| +1% | +$8.91K | 0.01% | 711 |
|
|
2014
Q3 | $530K | Hold |
53,048
| – | – | 0.01% | 779 |
|
|
2014
Q2 | $526K | Buy |
+53,048
| New | +$470K | 0.01% | 672 |
|
Other funds holding DXCM
United Capital Financial Advisors's DXCM Position: Q2 2026 in Review
United Capital Financial Advisors reduced its DexCom (DXCM) stake by 1.7% in Q2 2026, selling an estimated $21.7K and leaving 19,104 shares worth $1.29M. The position accounts for 0.01% of the portfolio, ranked #714.
United Capital Financial Advisors first reported a position in DXCM in Q2 2014 and has held it in 49 quarters since. The position peaked at $4M in Q1 2022. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- United Capital Financial Advisors held 19,104 shares of DexCom worth $1.29M as of Q2 2026.
- United Capital Financial Advisors sold 326 DexCom shares in Q2 2026, an estimated $21.7K.
- DexCom made up 0.01% of United Capital Financial Advisors's portfolio in Q2 2026, its #714 holding.
- United Capital Financial Advisors first reported a position in DexCom in Q2 2014 and has held it in 49 quarters since.
- United Capital Financial Advisors's DexCom position peaked at $4M in Q1 2022.
- 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on United Capital Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.